About Transcription factor NF-E2 45 kDa subunit
Transcription factor NF-E2 45 kDa subunit (NFE2) is a protein
from Homo sapiens identified by UniProt accession
Q16621, 373 residues long.
MolForge cross-references it against 0 known binders and
253 disease associations.
Target properties
| Protein name | Transcription factor NF-E2 45 kDa subunit |
| UniProt accession | Q16621 |
| Gene | NFE2 |
| Organism | Homo sapiens |
| Length | 373 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (253)
Diseases linked to this target (Open Targets).
- mean platelet volume · score 0.37
- mean corpuscular volume · score 0.35
- eosinophil count · score 0.35
- Red cell distribution width · score 0.35
- blood protein measurement · score 0.34
- monocyte count · score 0.34
- mean corpuscular hemoglobin concentration · score 0.34
- mean corpuscular hemoglobin · score 0.33
- platelet count · score 0.32
- erythrocyte count · score 0.32
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q16621-F1 | alphafold | PREDICTED | 66.33 | — |
Amino-acid sequence (373 residues)
MSPCPPQQSR NRVIQLSTSE LGEMELTWQE IMSITELQGL NAPSEPSFEP QAPAPYLGPP PPTTYCPCSI HPDSGFPLPP PPYELPASTS HVPDPPYSYG NMAIPVSKPL SLSGLLSEPL QDPLALLDIG LPAGPPKPQE DPESDSGLSL NYSDAESLEL EGTEAGRRRS EYVEMYPVEY PYSLMPNSLA HSNYTLPAAE TPLALEPSSG PVRAKPTARG EAGSRDERRA LAMKIPFPTD KIVNLPVDDF NELLARYPLT ESQLALVRDI RRRGKNKVAA QNCRKRKLET IVQLERELER LTNERERLLR ARGEADRTLE VMRQQLTELY RDIFQHLRDE SGNSYSPEEY ALQQAADGTI FLVPRGTKME ATD
Explore Transcription factor NF-E2 45 kDa subunit with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets